Accel-Amplicon Pharmacogenetics Panel

  • Germline screening of 153 ADME-related genes for drug interactions
  • Single-tube, 2-hour workflow
  • Inputs as low as 10 ng
  • Amplicons sized 120-160 bp for compatibility with cfDNA and FFPE
  • Limit of detection as low as 1%
  • On-target specificity and coverage uniformity > 95%
  • Includes sequencing adapters

Accel-Amplicon panels are based on a unique molecular biology that provides powerful solutions for detecting and screening clinically-relevant mutations. Swift Biosciences’ multiplex amplicon panels are comprised of 10’s to 100’s of primer pairs in a single-tube format which are optimized for sequencing on Illumina® platforms. Primer pairs in the panels are designed for compatibility with the short DNA fragments from both formalin-fixed, paraffin-embedded (FFPE) and circulating, cell-free DNA (cfDNA) samples.

A fast and easy single-tube workflow produces the best-in-class performance for on-target percentage and coverage uniformity, enabling variant discovery and confirmation.

Available soon

The Accel-Amplicon Pharmacogenetics panel will be available soon. 

Contact us to receive documentation and pricing as soon as it is available.

Resources

Ordering information

Westburg offers this product in The Netherlands, Belgium, Luxembourg,
If you are not located in these countries please visit the Swift Biosciences website to find your local distributor.
Cat no. Description
SW AL-54048 Accel-Amplicon Pharmacogenetics Panel (48 reactions)